Doctors
Professor Con Yiannikas
Professor Con Yiannikas is a Clinical Professor of Neurology at Sydney University and a Senior Visiting Neurologist at Royal North Shore and Concord Repatriation General Hospitals.
Prof Yiannikas is director of Inner West Neurology and has longstanding expertise in multiple subspecialty areas of neurology. In particular, he runs clinics specialising in neurophysiology, neuromuscular disease, multiple sclerosis, and movement disorders. He has a strong interest in education and provides postgraduate education in neurophysiology and injectable therapies techniques, and runs a regular national training programme for young injectors. His research interests are broad, and have included the neurophysiological assessment of movement disorders, the clinical applications of botulinum toxin, as well as the origins of evoked potentials and their clinical application in several conditions including multiple sclerosis. (Greek speaking)
Dr Michael Fong
Dr Michael Fong (BMedSc, MBBS(Hons), FRACP, JP) Dr. Michael Fong is a Neurologist and sub-specialty Epilepsy Physician. Alongside his private practice, he holds appointments at the Westmead Hospital Comprehensive Epilepsy Unit (one of the largest epilepsy services in NSW) and the Children’s Hospital at Westmead. Having completed his medical training at The University of Sydney, Dr. Fong’s general neurology training was undertaken at several tertiary Sydney hospitals, including Prince of Wales Hospital and Westmead Hospital. His first epilepsy fellowship was at Westmead Hospital. Dr. Fong then furthered his epilepsy training at the Yale Comprehensive Epilepsy Center, New Haven, CT, USA. While working at Yale, Dr. Fong trained with many of the pioneers of epilepsy surgery and world leaders in epilepsy management. Dr. Fong is particularly trained in medically refractory epilepsy (i.e., epilepsy that is not controlled by medications), which includes the discussion of epilepsy surgery and use of implantable devices for the reduction of seizures.
Research is an important part of Dr. Fong’s practice. He is currently completing his PhD with The University of Sydney, in the areas of medically refractory epilepsy and EEG monitoring in critically ill patients. Dr. Fong holds the positions of Assistant Professor Adjunct at the Yale School of Medicine, CT, USA, and Clinical Lecturer with The University of Sydney.
Dr Matthew Silsby
Dr Matt Silsby (JP, BMedSc, MBBS(Hons), PhD, FRACP) is a specialist Neurologist and Clinical Neurophysiologist. He completed medical school at Sydney University and graduated with Honours. He is currently a Staff Specialist Neurologist at Westmead Hospital where he is also the Director of Neurophysiology and Neuromuscular Services. His PhD evaluated movement disorders (such as tremor) associated with demyelinating neuropathies. He remains active in clinical research including in the areas of neurophysiology techniques and neuropathies, and is the Principal Investigator for the Amyloidosis Clinical Trials Unit at Westmead Hospital. He also has expertise in the use of injectable therapies for the treatment of neurological disorders including chronic migraine, abnormal movements, spasticity, and hyperhidrosis.
Dr Silsby is committed to the ongoing education of neurologists and healthcare professionals. He coordinates a unit of study at Sydney University in the Master of Medicine (Clinical Neurophysiology) degree. He was a co-founder of the Neuromuscular Society of Australia and New Zealand (NMSANZ), dedicated to improving the diagnosis and management of neuromuscular disorders.
Dr Rajiv Wijesinghe
Dr Rajiv Wijesinghe is a general neurologist, with expertise in the management of headache, stroke and neuromuscular disorders. He completed his training through Royal Prince Alfred and Concord Hospitals in Sydney. He has received subspeciality training in conducting comprehensive neurophysiological assessments and using injectable therapies for treatment of neurological disorders such as chronic migraine, cervical dystonia and hyperhidrosis.
Dr Shadi El-Wahsh
Dr Shadi El-Wahsh is a neurologist and clinical neurophysiologist. He has a broad interest across all neurological conditions with a special interest in nerve and muscle disorders and headache. He completed his clinical training at Royal Prince Alfred and Concord Hospitals and was awarded the ANZAN fellowship to undertake further neurology training at the world-renowned National Hospital for Neurology and Neurosurgery in London, UK. He has extensive training in nerve conduction studies and electromyography (EMG) as well as botulinum toxin therapy for the treatment of neurological disorders. He is a conjoint academic at the University of Sydney and the University of New South Wales.
Dr Nathan Pavey
Dr Nathan Pavey (B. Biomedical Sci, MBBS(Hons) PhD FRACP) is a Neurologist and Neurophysiologist, with special interest in the diagnosis and management of neuromuscular disorders. Additionally, he has expertise in the use of injectable therapies for neurological conditions including chronic migraine, hyperhydrosis, spasticity, and dystonia.
Following physician training in Newcastle NSW, he undertook specialist neurology training at Gosford and St George Hospitals, with further subspecialty training in neurophysiology and EMG, neuromuscular disorders and neuroimmunology at Westmead Hospital.
Dr Pavey is part of the multidisciplinary research team at the Brain and Nerve Research Centre, Concord Repatriation General Hospital that engages in furthering the understanding of motor neurone disease and related conditions and facilitates clinical treatment trials. He completed his PhD candidate at University of Sydney focussing on the investigation of brain and nerve dysfunction in motor neurone disease and related conditions using transcranial magnetic stimulation and novel neurophysiological techniques. He has ongoing involvement in the education and training of medical students and doctors in training.
Dr Laura Rudaks
Dr Laura Rudaks (MBBS, FRACP) is a Neurologist with particular interest in the diagnosis and management of neuromuscular and neurogenetic disorders. She completed her Neurology training at the Sydney Adventist and Royal North Shore Hospitals. She undertook a fellowship in mitochondrial disorders at Royal North Shore Hospital and a further fellowship in neuromuscular and neurophysiology at Concord Repatriation General Hospital. She has subspecialty training in neurophysiology and injectable treatment for neurologic conditions including chronic migraine, dystonia, spasticity, and hyperhidrosis. Dr Rudaks also consults at the Neurofibromatosis Clinic at Royal North Shore Hospital. She completed a Master of Medicine in Genomics and Precision medicine at the University of Sydney and is a current PhD candidate, undertaking research in advanced genomics for the diagnosis of neurogenetic disorders.
Dr Nimalan Harinesan
Dr. Nimalan Harinesan is a leading neurologist specialising in multiple sclerosis (MS), autoimmune neurological disorders, and neurophysiology. He completed his Bachelor of Science and medical degree at the University of Sydney, followed by clinical training at Concord, Liverpool, and Westmead Hospitals.
Dr. Harinesan further honed his expertise through a prestigious fellowship in Autoimmune Neurology and Advanced Clinical Neurology at the Mayo Clinic in Rochester, Minnesota—a globally recognised centre for research and patient care in autoimmune neurological disorders. There he was involved in cutting-edge clinical and translational research, focusing on immune-inflammatory diseases of the central nervous system (CNS), including autoimmune encephalitis, neuromyelitis optica, stiff-person syndrome, paraneoplastic neurological syndromes and MS.
Dr. Harinesan has published extensively in peer-reviewed journals, contributing to the advancement of knowledge in autoimmune neurology. He has also presented his research at international conferences, sharing his expertise with the global medical community.
Dr. Harinesan is committed to delivering personalised, evidence-based care to patients with complex neurological conditions. His approach integrates the latest advancements in neurophysiology and autoimmune neurology to provide comprehensive diagnostic and therapeutic services.